
Sangal Papers (SANPA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
475.7M
Gross Profit
62.2M
13.07%
Operating Income
15.0M
3.15%
Net Income
8.0M
1.69%
EPS (Diluted)
₹6.15
Balance Sheet Metrics
Total Assets
924.9M
Total Liabilities
481.5M
Shareholders Equity
443.4M
Debt to Equity
1.09
Cash Flow Metrics
Revenue & Profitability Trend
Sangal Papers Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.8B | 1.9B | 2.3B | 1.5B | 1.1B |
Cost of Goods Sold | 1.6B | 1.7B | 2.0B | 1.3B | 887.4M |
Gross Profit | 244.8M | 220.4M | 240.4M | 201.3M | 168.5M |
Gross Margin % | 13.6% | 11.6% | 10.7% | 13.0% | 16.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 61.2M | 78.5M | 66.0M | 41.0M |
Other Operating Expenses | 79.2M | 8.6M | 11.0M | 6.3M | 11.4M |
Total Operating Expenses | 79.2M | 69.8M | 89.6M | 72.3M | 52.4M |
Operating Income | 58.9M | 54.6M | 54.4M | 39.4M | 32.3M |
Operating Margin % | 3.3% | 2.9% | 2.4% | 2.5% | 3.1% |
Non-Operating Items | |||||
Interest Income | - | 260.0K | 61.0K | 13.0K | 148.0K |
Interest Expense | 25.3M | 25.2M | 19.4M | 15.5M | 15.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 40.0M | 34.7M | 48.0M | 21.2M | 7.6M |
Income Tax | 11.8M | 10.0M | 14.1M | 4.8M | 1.1M |
Effective Tax Rate % | 29.4% | 28.8% | 29.4% | 22.5% | 14.6% |
Net Income | 28.3M | 24.7M | 33.9M | 16.4M | 6.5M |
Net Margin % | 1.6% | 1.3% | 1.5% | 1.1% | 0.6% |
Key Metrics | |||||
EBITDA | 84.5M | 77.5M | 84.2M | 58.4M | 49.7M |
EPS (Basic) | ₹21.62 | ₹18.90 | ₹25.90 | ₹12.55 | ₹5.00 |
EPS (Diluted) | ₹21.62 | ₹18.90 | ₹25.90 | ₹12.55 | ₹5.00 |
Basic Shares Outstanding | 1306984 | 1307260 | 1307260 | 1307260 | 1307000 |
Diluted Shares Outstanding | 1306984 | 1307260 | 1307260 | 1307260 | 1307000 |
Income Statement Trend
Sangal Papers Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 8.3M | 13.1M | 9.6M | 1.4M | 1.4M |
Short-term Investments | 1.1M | 1.1M | 1.0M | - | 858.0K |
Accounts Receivable | 269.4M | 248.8M | 285.6M | 246.0M | 244.3M |
Inventory | 229.3M | 228.6M | 222.4M | 165.4M | 133.6M |
Other Current Assets | 20.2M | 4.6M | 4.1M | 2.5M | 2.5M |
Total Current Assets | 528.4M | 505.6M | 533.7M | 421.8M | 389.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | 395.0M | 137.6M | 137.6M | 114.6M | 113.6M |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | 13.0M | 2.9M | 15.6M | 1.0K |
Total Non-Current Assets | 396.5M | 390.7M | 367.6M | 321.2M | 320.5M |
Total Assets | 924.9M | 896.2M | 901.3M | 743.1M | 710.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 124.1M | 137.3M | 182.1M | 129.6M | 120.8M |
Short-term Debt | 174.8M | 163.1M | 152.5M | 106.6M | 114.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 11.9M | 7.5M | 16.3M | 9.5M | 7.3M |
Total Current Liabilities | 330.8M | 327.4M | 366.1M | 260.0M | 257.5M |
Non-Current Liabilities | |||||
Long-term Debt | 93.6M | 101.9M | 96.8M | 85.1M | 72.9M |
Deferred Tax Liabilities | 48.4M | 43.6M | 39.5M | 33.6M | 32.6M |
Other Non-Current Liabilities | - | -2.0K | - | - | - |
Total Non-Current Liabilities | 150.7M | 153.3M | 143.9M | 125.2M | 111.3M |
Total Liabilities | 481.5M | 480.7M | 510.0M | 385.2M | 368.8M |
Equity | |||||
Common Stock | 13.1M | 13.1M | 13.1M | 13.1M | 13.1M |
Retained Earnings | - | 397.6M | 373.4M | 339.9M | 323.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 443.4M | 415.6M | 391.3M | 357.9M | 341.5M |
Key Metrics | |||||
Total Debt | 268.5M | 265.0M | 249.3M | 191.7M | 187.4M |
Working Capital | 197.6M | 178.2M | 167.6M | 161.8M | 132.3M |
Balance Sheet Composition
Sangal Papers Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 40.0M | 34.7M | 48.0M | 21.2M | 7.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -10.4M | 17.3M | -83.2M | -44.9M | -5.1M |
Operating Cash Flow | 54.7M | 76.9M | -15.9M | -8.3M | 18.2M |
Investing Activities | |||||
Capital Expenditures | -44.5M | -30.2M | -83.7M | -10.2M | -34.9M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -40.8M | -30.1M | -75.0M | -768.0K | -34.8M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | 5.1M | 11.7M | 12.2M | 10.4M |
Debt Repayment | -8.3M | - | - | -7.9M | -26.9M |
Financing Cash Flow | 3.5M | 15.6M | 57.6M | -3.7M | -43.5M |
Free Cash Flow | 13.2M | 12.8M | -38.8M | 2.0M | 32.2M |
Net Change in Cash | 17.4M | 62.5M | -33.3M | -12.7M | -60.1M |
Cash Flow Trend
Sangal Papers Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
9.68
Price to Book
0.65
Price to Sales
0.15
PEG Ratio
0.47
Profitability Ratios
Profit Margin
1.60%
Operating Margin
3.47%
Return on Equity
6.37%
Return on Assets
3.06%
Financial Health
Current Ratio
1.60
Debt to Equity
60.54
Beta
-0.68
Per Share Data
EPS (TTM)
₹22.67
Book Value per Share
₹338.79
Revenue per Share
₹1,417.20
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
sanpa | 268.0M | 9.68 | 0.65 | 6.37% | 1.60% | 60.54 |
Aditya Birla Real | 193.4B | 163.88 | 5.09 | -4.15% | -19.06% | 128.50 |
Jk Paper | 63.6B | 18.31 | 1.17 | 7.25% | 5.26% | 33.33 |
West Coast Paper | 26.9B | 13.34 | 0.96 | 7.64% | 6.19% | 11.20 |
Seshasayee Paper | 18.2B | 18.25 | 0.80 | 5.49% | 5.10% | 4.12 |
Andhra Paper | 15.4B | 18.70 | 0.80 | 4.58% | 5.10% | 14.59 |
Financial data is updated regularly. All figures are in the company's reporting currency.